메뉴 건너뛰기




Volumn 44, Issue 5, 2005, Pages 490-495

A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer

Author keywords

Bowen's disease; Myelodysplastic syndrome; Myelofibrosis; Ovarian cancer; TP53

Indexed keywords

ARGININE; CARBOPLATIN; CYCLOSPORIN A; DOCETAXEL; HISTIDINE; MELPHALAN; PREDNISOLONE; PROTEIN P53;

EID: 21244500548     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.490     Document Type: Article
Times cited : (10)

References (24)
  • 1
    • 0035379034 scopus 로고    scopus 로고
    • Chromosome and molecular abnormalities in myelodysplastic syndromes
    • Fenaux P. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol 73: 429-437, 2001.
    • (2001) Int. J. Hematol. , vol.73 , pp. 429-437
    • Fenaux, P.1
  • 2
    • 0027247412 scopus 로고
    • Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia
    • Sugimoto K, Hirano N, Toyoshima. H, et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 81: 3022-3326, 1993.
    • (1993) Blood , vol.81 , pp. 3022-3326
    • Sugimoto, K.1    Hirano, N.2    Toyoshima, H.3
  • 3
    • 0028955808 scopus 로고
    • TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities
    • Kaneko H, Misawa S, Horiike S, Nakai H, Kashima K. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 85: 2189-2193, 1995.
    • (1995) Blood , vol.85 , pp. 2189-2193
    • Kaneko, H.1    Misawa, S.2    Horiike, S.3    Nakai, H.4    Kashima, K.5
  • 4
    • 0030463176 scopus 로고    scopus 로고
    • TP53 mutations in myelodysplastic syndrome
    • Misawa S, Horiike S. TP53 mutations in myelodysplastic syndrome. Leuk Lymphoma 23: 417-422, 1996.
    • (1996) Leuk. Lymphoma , vol.23 , pp. 417-422
    • Misawa, S.1    Horiike, S.2
  • 5
    • 0026096185 scopus 로고
    • P53 gene mutations in acute myeloid leukemia with 17p monosomy
    • Fenaux P, Jonveaux P, Quiquandon I, et al. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 78: 1652-1657, 1991.
    • (1991) Blood , vol.78 , pp. 1652-1657
    • Fenaux, P.1    Jonveaux, P.2    Quiquandon, I.3
  • 6
    • 0033952799 scopus 로고    scopus 로고
    • Lowdose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia
    • Denzlinger C, Bowen D, Benz D, Gelly K, Brugger W, Kanz L. Lowdose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia. Br J Haematol 108: 93-95, 2000.
    • (2000) Br. J. Haematol. , vol.108 , pp. 93-95
    • Denzlinger, C.1    Bowen, D.2    Benz, D.3    Gelly, K.4    Brugger, W.5    Kanz, L.6
  • 7
    • 0035725856 scopus 로고    scopus 로고
    • International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome
    • Kita-Sasai Y, Horiike S, Misawa S, et al. International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome. Br J Haematol 115: 309-312, 2001.
    • (2001) Br. J. Haematol. , vol.115 , pp. 309-312
    • Kita-Sasai, Y.1    Horiike, S.2    Misawa, S.3
  • 8
    • 0028871987 scopus 로고
    • Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia
    • Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86: 3542-3552, 1995.
    • (1995) Blood , vol.86 , pp. 3542-3552
    • Pedersen-Bjergaard, J.1    Pedersen, M.2    Roulston, D.3    Philip, P.4
  • 9
    • 0027241670 scopus 로고
    • p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin
    • Campbell C, Quinn AG, Ro YS, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100: 746-748, 1993.
    • (1993) J. Invest. Dermatol. , vol.100 , pp. 746-748
    • Campbell, C.1    Quinn, A.G.2    Ro, Y.S.3    Angus, B.4    Rees, J.L.5
  • 10
    • 0030909092 scopus 로고    scopus 로고
    • p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light
    • Takata M, Rehman I, Rees JL. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light. Int J Cancer 71: 370-372, 1997.
    • (1997) Int. J. Cancer , vol.71 , pp. 370-372
    • Takata, M.1    Rehman, I.2    Rees, J.L.3
  • 11
    • 0034730951 scopus 로고    scopus 로고
    • p53 gene mutations in Bowen's disease in Koreans: Clustering in exon 5 and multiple mutations
    • Lee HJ, Kim JS, Ha SJ, et al. p53 gene mutations in Bowen's disease in Koreans: clustering in exon 5 and multiple mutations. Cancer Lett 158: 27-33, 2000.
    • (2000) Cancer Lett. , vol.158 , pp. 27-33
    • Lee, H.J.1    Kim, J.S.2    Ha, S.J.3
  • 12
    • 0035099665 scopus 로고    scopus 로고
    • Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease
    • Kawakami T, Soma Y, Mizoguchi M, Saito R. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease. Dermatology 202: 9-15, 2001.
    • (2001) Dermatology , vol.202 , pp. 9-15
    • Kawakami, T.1    Soma, Y.2    Mizoguchi, M.3    Saito, R.4
  • 14
    • 0025876591 scopus 로고
    • The p53 tumour suppressor gene
    • Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
    • (1991) Nature , vol.351 , pp. 453-456
    • Levine, A.J.1    Momand, J.2    Finlay, C.A.3
  • 15
    • 0030752030 scopus 로고    scopus 로고
    • Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects
    • Hainaut P, Soussi T, Shomer B, et al. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res 25: 151-157, 1997.
    • (1997) Nucleic Acids Res. , vol.25 , pp. 151-157
    • Hainaut, P.1    Soussi, T.2    Shomer, B.3
  • 16
    • 0031804515 scopus 로고    scopus 로고
    • A database of germline p53 mutations in cancer-prone families
    • Sedlacek Z, Kodet R, Poustka A, Goetz P. A database of germline p53 mutations in cancer-prone families. Nucleic Acids Res 26: 214-215, 1998.
    • (1998) Nucleic Acids Res. , vol.26 , pp. 214-215
    • Sedlacek, Z.1    Kodet, R.2    Poustka, A.3    Goetz, P.4
  • 17
    • 0034137259 scopus 로고    scopus 로고
    • Therapy-related leukemia and myelodysplastic syndrome: A large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors
    • Takeyama K, Seto M, Uike N, et al. Therapy-related leukemia and myelodysplastic syndrome: A large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol 71: 144-152, 2000.
    • (2000) Int. J. Hematol. , vol.71 , pp. 144-152
    • Takeyama, K.1    Seto, M.2    Uike, N.3
  • 18
    • 0043098293 scopus 로고    scopus 로고
    • The myelodysplastic syndromes: Morphology, risk assesment, and clinical management (2002)
    • Bennett JM, Kouides PA, Forman SJ. The myelodysplastic syndromes: Morphology, risk assesment, and clinical management (2002). Int J Hematol 76 (suppl 2): 228-238, 2002.
    • (2002) Int. J. Hematol. , vol.76 , Issue.SUPPL. 2 , pp. 228-238
    • Bennett, J.M.1    Kouides, P.A.2    Forman, S.J.3
  • 19
    • 0028593972 scopus 로고
    • Precursors to skin cancer
    • Sober AJ, Burstein JM. Precursors to skin cancer. Cancer 75 (Suppl 2): 645-650, 1995.
    • (1995) Cancer , vol.75 , Issue.SUPPL. 2 , pp. 645-650
    • Sober, A.J.1    Burstein, J.M.2
  • 20
    • 0037219841 scopus 로고    scopus 로고
    • TP53 and ovarian cancer
    • Schuijer M, Berns EM. TP53 and ovarian cancer. Hum Mutat 21: 285-291, 2003.
    • (2003) Hum. Mutat. , vol.21 , pp. 285-291
    • Schuijer, M.1    Berns, E.M.2
  • 21
    • 0023873472 scopus 로고
    • High-dose intravenous methylprednisolone, for idiopathic myelofibrosis
    • Ozsoylu S. High-dose intravenous methylprednisolone, for idiopathic myelofibrosis. Lancet 1: 766, 1988.
    • (1988) Lancet , vol.1 , pp. 766
    • Ozsoylu, S.1
  • 22
    • 0026816322 scopus 로고
    • Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone
    • (in Japanese)
    • Tanosaki R, Uchida H, Masuda Y, et al. Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone. Rinsho Ketsueki (Jpn J Clin Hematol) 33: 256-258, 1992 (in Japanese).
    • (1992) Rinsho Ketsueki (Jpn. J. Clin. Hematol.) , vol.33 , pp. 256-258
    • Tanosaki, R.1    Uchida, H.2    Masuda, Y.3
  • 23
    • 0028106393 scopus 로고
    • Idiopathic myelofibrosis: Anaemia may respond to low-dose dexamethasone
    • Jack FR, Smith SR, Saunders PW. Idiopathic myelofibrosis: anaemia may respond to low-dose dexamethasone. Br J Haematol 87: 877-878, 1994.
    • (1994) Br. J. Haematol. , vol.87 , pp. 877-878
    • Jack, F.R.1    Smith, S.R.2    Saunders, P.W.3
  • 24
    • 0030095637 scopus 로고    scopus 로고
    • Primary myelofibrosis with positive coombs' test responding to prednisolone
    • (in Japanese)
    • Yumoto Y, Okuda T, Yoshida Y. Primary myelofibrosis with positive coombs' test responding to prednisolone. Rinsho, Ketsueki (Jpn J Clin Hematol) 37: 255-259, 1996 (in Japanese).
    • (1996) Rinsho, Ketsueki (Jpn. J. Clin. Hematol.) , vol.37 , pp. 255-259
    • Yumoto, Y.1    Okuda, T.2    Yoshida, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.